Building a Science Institute for the 21st Century

Scripps Research is pioneering a new model for nonprofit research institutes to address the significant health challenges facing humanity in the 21st century, from pandemic threats to the aging of the global population. Founded 100 years ago, Scripps Research is renowned in the life sciences and chemistry for scientific excellence and for training the scientific leaders of tomorrow.

Building on this solid foundation, we have established a unique model that seamlessly combines world-class fundamental and translational research to accelerate the development of innovative, new medicines. We believe this model best captures the impact of groundbreaking discoveries for the benefit of human health.

Moreover, revenues generated from these new medicines are reinvested into research, creating a self-renewing funding source and business model that amplifies investments in science and their ultimate impact on the public.

Learn More

Driving Scientific Discovery

Ranked by Nature Index among the world's top five most innovative institutes, we empower scientists to pursue high-risk, high-reward ideas that transform our understanding of the world around us and lead to new technologies that shape that world.

Through our Skaggs Graduate School of Chemical and Biological Sciences we’re inspiring and training the next generation of scientific leaders, ensuring the continued trajectory of scientific excellence for generations to come.

Research Areas

Shaping the Future of Medicine

In addition to leading the way in curiosity-fueled science, Scripps Research has emerged as a world leader in translational research, including drug discovery and advances in individualized and digital medicine.

The Calibr-Skaggs Institute for Innovative Medicines and the Scripps Research Translational Institute (SRTI), unique in the nonprofit research sector, are dedicated to turning scientific discoveries into real-world medical advances, including preventative approaches, diagnostics and new medicines.

Disease Areas

Amplifying Investment in Science

By turning scientific discoveries into new medicines, Scripps Research is not only impacting human health, but also creating a self-renewing revenue stream from partnering these medicines with pharma for further development.

These licensing revenues are then reinvested into our research programs, ensuring a continuous stream of scientific breakthroughs and a strong pipeline of next-generation transformative medicines.

Explore Our Model

An error has occurred, please try again later